Author:
Sekercioglu Nigar,Busse Jason W.,Mustafa Reem A.,Guyatt Gordon H.,Thabane Lehana
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69(11):1945–53.
2. Omata M, Fukagawa M, Kakuta T. Vascular calcification—pathological mechanism and clinical application-. Vascular calcification in chronic kidney disease-mineral and bone disorder (CKD-MBD). Clin Calcium. 2015;25(5):645–53.
3. Wetmore JB, Quarles LD. Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol. 2009;5(1):24–33.
4. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol CJASN. 2011;6(4):913–21.
5. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med. 2004;350(15):1516–25.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献